Yang Li, PhD

Dr. Yang Li is the Executive Vice President of Research at Surrozen. Dr. Li is a distinguished scientist and a well-recognized leader in the Wnt field with over 90 high-impact publications and numerous patents. With over 25 years of experience in the biopharmaceutical industry, Dr. Li has a proven track record of advancing drug molecules from initial concept to clinical application.

His career is marked by successes in translating complex biological concepts into clinical-stage candidates. During his tenure as Scientific Director at Amgen, his leadership was instrumental in progressing various therapeutic programs into the clinic. Dr. Li’s academic foundation includes a Ph.D. in Cell Biology from Stanford University, as well as dual B.S. degrees in Chemistry and Molecular and Cell Biology from Pennsylvania State University.